Latest filing published 29 Mar 2022 for HEALTHWAY MEDICAL CORPORATION LIMITED.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Abram Melkyzedeck Suhardiman: trading record in brief
Abram Melkyzedeck Suhardiman discloses dealings in Healthway Medical Corporation Limited to SGX. In total, 5 filings cover trades dated from 29 September 2020 to 29 March 2022.
No open-market sale appears; the market trades are 4 purchases worth €1.4M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
In size, the median ticket on the buying side is €342k. Across 4 purchases, this insider has always bought alone, with no colleague buying within 30 days.
Most recently, on 29 March 2022, the filings show a transaction in Healthway Medical Corporation Limited. The last purchase on record was published on 3 June 2021, which is 1,984 days ago. Half of the filings or more reach the SGX feed on the day of the trade. This delay matters because a trade only becomes useful information once it is public. This summary is built from SGX disclosures alone and does not predict where the share price will go.
Companies and markets linked to Abram Melkyzedeck Suhardiman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- ShareSGX-STISIN SG1X09940682SGX:YQKR32RJF94YQFBS
- 26,739,200 shares@ SGD 0.031138.0% of flowShareSGX-STISIN SG1X09940682SGX:9LFBNJO6R45SD0UUCanonical exit: 1 Sept 2021 (T+90)
- 3,226,800 shares@ SGD 0.0324.8% of flowShareSGX-STISIN SG1X09940682SGX:BIBKTDPSNAA1E013Canonical exit: 12 Jan 2021 (T+90)
- 30,500,000 shares@ SGD 0.03244.9% of flowShareSGX-STISIN SG1X09940682SGX:DCQ6EJC3WXT9RUUWCanonical exit: 5 Jan 2021 (T+90)
- 8,452,900 shares@ SGD 0.03212.4% of flowShareSGX-STISIN SG1X09940682SGX:Y3CQVI3IKZ5GNZBFCanonical exit: 28 Dec 2020 (T+90)
5 of 5 declarations